Javitt Daniel C. 13D and 13G filings for NRx Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2022-09-13 4:47 pm Purchase | 2022-07-01 | 13D | NRx Pharmaceuticals, Inc. NRXP | Javitt Daniel C. | 987,290 14.600% | 987,290![]() (New Position) | Filing |